Yale University
Clinical research site in New Haven, Connecticut · 310 CEDAR ST, 416A LAUDER HALL, NEW HAVEN, CT 06510-3218 · (203) 785-6843
Part of Yale University
As of September 2026, 268 paid clinical trials are recruiting at Yale University in New Haven, Connecticut. Active studies at this site cover conditions such as Acute Myeloid Leukemia, Alcohol Use Disorder and Stage IV Lung Cancer AJCC v8. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Yale University (268)
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
DALY II USA/ MB-CART2019.1 for DLBCL
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
SELUTION4BTK Trial
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
The ArtixASCEND Study
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
RevCore for In Stent Thrombosis
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
The PERSEVERE Study
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
The Pivotal Study of RapidPulseTM Aspiration System
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Showing the 40 most relevant of 268 recruiting trials at this site. Browse all with filters →
Get new-trial alerts for Yale University
We'll email you whenever a new clinical trial starts recruiting at this research site in New Haven, CT. Unsubscribe anytime.
More research sites in New Haven
- Yale Cancer Center (67 trials)
- Yale New Haven Hospital (63 trials)
- Yale University School of Medicine (59 trials)
- Yale School of Medicine (41 trials)
- Smilow Cancer Center/Yale-New Haven Hospital (20 trials)
- Yale (12 trials)
- Yale-New Haven Hospital (12 trials)
- Connecticut Mental Health Center (11 trials)
- GSK Investigational Site (8 trials)
- Smilow Cancer Hospital at Yale New Haven (8 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in New Haven, CT · Connecticut clinical trials